Biopharma In Sweden: A Comfortable Climate For Start-Ups
Executive Summary
Sweden’s biopharmaceutical and life sciences industry now makes up a key part of the country's economy, and the climate is ripe for biotech start-ups.
You may also be interested in...
Swecure AB
There are many treatments on the market and in development that ease the symptoms of allergies, from antihistamines to immunotherapies, but there is no real prevention or cure. Swedish biotech Swecure AB aims to prevent the development of allergies in the first place: its research is based on a bacterial protein, known as a superantigen, found in the gut flora of newborn babies.
Northern Light Pharmaceuticals AB
Swedish start-up Northern Light Pharmaceuticals AB spun out of AstraZeneca AB with a portfolio of early-stage products designed to meet the aging population’s unmet needs in treating cancer, inflammatory pain, and neurological disorders.
Sigrid Therapeutics
Sigrid Therapeutics was spun out from Stockholm-based Nanologica AB to develop treatments for obesity. The start-up’s lead project is an oral formulation of porous silica designed to reduce the absorption of fat from food and help people with a BMI of more than 30 to lose weight.